Nitinol Devices & Components
Reference Library - Confluent Medical
About Nitinol Devices & Components
Nitinol.com specializes in the development and manufacturing of advanced shape memory alloys, primarily focusing on nickel-titanium (Nitinol) materials. These alloys are known for their unique properties, including the ability to return to a predefined shape when heated, making them highly valuable in various applications. The company serves a diverse range of clients, including those in the medical device industry, aerospace, and automotive sectors. Nitinol.com's business model revolves around providing high-quality, custom-engineered Nitinol components that meet the specific needs of their clients. They generate revenue through the sale of these specialized materials and components, often working on a contract manufacturing basis. The company operates in a niche market, leveraging its expertise in metallurgy and materials science to deliver innovative solutions that enhance the performance and reliability of their clients' products.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1991
- Headquarters
- Scottsdale, United States
- Open positions
- None listed
- Dealroom signal
- 20.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Libraries, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
- Investment activity
- 2 companies, latest Mar 2015
- Capital deployed
- $20M
- Preferred round
- SERIES A
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Apr 2011 | $20M | $80M | Ampersand Capital Partners | — |
Growth signals
Latest recorded traffic for Nitinol Devices & Components is 170 monthly website visits, up 13.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SeptRxFremont, United StatesUnited states-based medical device company developing minimally invasive treatments for structural heart defects
$11Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Ampersand Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nitinol Devices & Components on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nitinol Devices & Components’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






